LIXT vs MCO · $121.0M cap vs P/E 33, rev $4.26B
Lixte Biotechnology Holdings Inc (LIXT) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Lixte Biotechnology Holdings Inc (LIXT) is a biotechnology company listed on NASDAQ.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
LIXT does not have a complete income-statement cache yet.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
LIXT currently screens at market cap $121.0M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the LIXT and MCO stock pages for the full models.
Not investment advice.